TRISALUS LIFE SCIENCES, INC.

Highlights TriSalus Life Sciences, Inc.

Equities

TLSI

US89680M1018

End-of-day quote Nasdaq Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
7.16 ^USD	-3.76%		-5.29%	-15.27%

May. 30	Canaccord Genuity Initiates TriSalus Life Sciences at Buy Rating With $12 Price Target	MT
May. 30	Canaccord Genuity Starts Coverage on TriSalus Life Sciences With Buy Rating, $12 Price Target	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

TriSalus Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 15	CI
Earnings Flash (TLSI) TRISALUS LIFE SCIENCES Posts Q1 Revenue $6.5M, vs. Street Est of $5.9M	May. 15	MT
TriSalus Life Sciences, Inc. Provides Sales Guidance for the Full Year of 2024	May. 15	CI
TriSalus Life Sciences Obtains $50 Million Debt Facility	May. 01	MT
TriSalus Life Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
TriSalus Life Sciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Apr. 01	CI
Earnings Flash (TLSI) TRISALUS LIFE SCIENCES Reports Q4 Revenue $5.7M	Apr. 01	MT
TriSalus Life Sciences, Inc. Provides Preliminary Unaudited Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2023; Provides Revenue Guidance for the Full Year 2024	Mar. 11	CI
Haystack Oncology Enters A Research Collaboration with TriSalus Life Sciences to Evaluate Therapeutic Response and Provide Molecular Insights in Connection with the Clinical Development of TriSalus' SD-101	Jan. 22	CI
TriSalus Life Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Earnings Flash (TLSI) TRISALUS LIFE SCIENCES Posts Q3 Revenue $5.2M	Nov. 14	MT
TriSalus Life Sciences, Inc. Presents Data for SD-101 Delivered by TriSalus Infusion System for Pancreatic Adenocarcinoma At the Society for Immunotherapy of Cancer Annual Meeting	Nov. 03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer